TERNS PHARMACEUTICALS, INC.

Company

Terns Pharmaceuticals, Inc.

Filed

March 7, 2024

Accession Number

0000902664-24-002264

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →